In a business steeped in risk, we focus on the basics, what we call the "S-E-C" of
biopharmaceuticals.  That is, we work to ensure that the target product label supports the
competitive  Safety, Efficacy, and/or Convenience to make a product successful.  We take
an objective, data-driven approach to science, development, and marketing. That way, we
work with you to Manage Risk.
  • Due Diligence for in-licensing and out-licensing candidates
  • Trouble-shooting of company plans, processes, and projects
  • In-depth KOL interviews and marketing research
  • New product assessment and development
  • Creation and testing of Target Product Profiles
  • Communications strategy and marketing messages
  • Message - Issue - Response - Support (MIRS) facilitation
  • Design and assessment of  clinical development programs
  • NDA document preparation and review
  • Scientific publications strategy
  • Proposals to acquire capital funding
  • Regulatory interaction preparation
  • Scientific support for sales training
"Everything should be made as simple as possible, but not simpler."--Albert Einstein
Recent Projects

    "Larry has extensive personal networks and in-depth knowledge in many different
    biotechnology areas. I enjoyed working with him and would recommend his
    consulting services."

    Elizabeth Song, Ph.D.
    VP Business Development EGeen International Corporation

    "Larry was able to finesse the politics, bring his extensive industry experience and
    creatively solve problems. He utilized his scientific and business insight to help
    evaluate licensing opportunites as well as manage internal R&D. His broad
    therapeutic knowledge, sense of humor and tenacity are some of his strengths. He is
    respected because of his long career and many hands-on successes.”

    Debby Jo Blank, M. D.
    Senior VP Genencor